Pharmafile Logo
Pharmafocus logo
Advanced Search

France ‘to approve’ Avastin use

July 3, 2014
Sales and Marketing AMD, France, Lucentis, Novartis, Roche, avastin, off label, off-label, wet AMD

The French government is planning to allow Roche’s cancer drug Avastin to be prescribed off-label to treat wet age-related macular …

News
Genentech image

Genentech to buy Seragon

July 3, 2014
Sales and Marketing Genentech, Roche, breast cancer, oncology, serds

Roche subsidiary Genentech is to pay around $1.7 billion for biotech firm Seragon Pharmaceuticals to secure its portfolio of potential …

News
annalisa_prosensa

Prosensa makes two key appointments



July 3, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Prosensa, Willem W. van Weperen. Annalisa Jenkins

Dutch biopharma firm Prosensa has appointed Willem W. van Weperen as chief commercial officer and Dr Annalisa Jenkins to its …

Appointment

World facing medical ‘dark ages’ over antibiotic resistance

July 2, 2014
Medical Communications, Research and Development, Sales and Marketing Antibiotics, BRIC, Cameron, MINT, UK, o'neill, oneill, resistance

The UK Government has pledged to become a world leader in tackling antibiotic resistance in the face of a medical …

News
Amgen image

FDA breakthrough for Amgen

July 2, 2014
Research and Development, Sales and Marketing Amgen, BiTE antibody blinatumomab, FDA, all, leukaemia

Amgen has taken a major step down the road to getting its investigational cancer drug blinatumomab onto the market after …

News
J&J image

J&J completes $4 billion OCD sale

July 2, 2014
Sales and Marketing J&J, JJ, Johnson and Johnson, Ortho-Clinical Diagnostics, carlyle, ocd

Johnson & Johnson has sold its Ortho-Clinical Diagnostics (OCD) business to private equity investor The Carlyle Group for ‘approximately $4 …

News

Fishawack buys Brighton comms agency

July 2, 2014
Medical Communications Brighton, Facilitate, comms, fishawack

Medical communications firm Fishawack has acquired the UK, Brighton-based agency Facilitate as part of its
 ongoing purchasing strategy. Facilitate will …

News
Merck image

PD-1 cancer race heats up as Merck takes lead

July 2, 2014
Research and Development, Sales and Marketing ASCO, Cancer, Merck, melanoma, mk3475, oncology, pembrolizumab

Merck’s oncology drug pembrolizumab has taken a big step towards becoming Europe’s first PD-1 cancer treatment as the EMA accepts …

News
james_smith_reuters_pfizer

Reuters chief executive joins Pfizer board

July 2, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, james smith, reuters

Pfizer has appointed the chief executive of information and media giant Thomson Reuters to its board of directors. James Smith …

Appointment

Doctors who miss cancer to be named and shamed

July 1, 2014
Sales and Marketing Cancer, GPs, Hunt, NHS, UK, doctors, oncology

In a new government initiative doctors who consistently fail to diagnose signs of cancer could be publically named on an …

News

BASF and chemical giants building new MDI plant

July 1, 2014
Manufacturing and Production BASF, China, Huntsman, SINOPEC, Shanghai, Shanghai Chlor-Alkali, Shanghai Hua Yi, mdi

BASF, Huntsman, Shanghai Hua Yi, Shanghai Chlor-Alkali and SINOPEC are teaming up to construct a new MDI plant in China. …

News
tatjana_dragovic_astellas

Astellas names Americas head

July 1, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Tatjana Dragovic, americas

Astellas has appointed Tatjana Dragovic as its VP and regional compliance officer for the firm’s Americas region. In this role …

Appointment
NHS image

Government gets £74m rebate from pharma

June 30, 2014
Sales and Marketing ABPI, Hunt, NHS, PPRS, VBP, emms, pricing

The UK government has received a £74 million refund from the pharma industry after it was deemed to have spent …

News
Affreza image

FDA ‘yes’ to inhaled insulin

June 30, 2014
Manufacturing and Production, Sales and Marketing Afrezza, FDA, Mannkind, diabetes, insulin human

The FDA has approved the first ‘ultra-rapid-acting’ mealtime insulin therapy available in the US, to improve glycemic control in both …

News
GSK China

GSK China sex tape ‘sent to Witty’

June 30, 2014
Medical Communications, Research and Development, Sales and Marketing China, GSK, Mark Reilly, Witty, corruption, sex tape

GlaxoSmithKline was scrambling to defend itself over the weekend as new details emerged concerning the extent of its suspected corruption …

News
BMS image

CHMP approves six drugs including daclatasvir

June 30, 2014
Sales and Marketing BMS, CHMP, HCV, Plavix, daclatasvir, daklinza, ge

A key advisory committee for the European Medicines Agency has given its approval to six new drugs at its latest …

News
catherine_brown_head_of_commercial_quantum_pharmaceutical

Quantum Pharmaceutical adds head of commercial

June 30, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing brown, quantum pharma

UK medicines supplier and manufacturing firm Quantum Pharmaceutical has expanded its team with the appointment of a new head of …

Appointment
ASCO image

Value tops the agenda at ASCO cancer conference

June 30, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ASCO, Cancer, chicago, mccafferty, oncology

The annual American Society of Clinical Oncology (ASCO) meeting has long been one of the most important events on the …

Feature
Glivec image

NICE U-turn on cancer drug despite price increase

June 27, 2014
Sales and Marketing Cancer, Glivec, NHS, Novartis, gists

UK pricing watchdog NICE has performed a U-turn on Glivec (imatinib) by issuing new draft guidance recommending the drug, despite …

News
astrazeneca image

FDA rejects olaparib

June 27, 2014
Sales and Marketing AstraZeneca, Cancer, FDA, PARP, adp, olaparib

AstraZeneca has been dealt a blow by a key advisory committee to the US Food and Drug Administration, which has …

News
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026